Chest
Consensus ConferenceClinical Indications for Noninvasive Positive Pressure Ventilation in Chronic Respiratory Failure Due to Restrictive Lung Disease, COPD, and Nocturnal Hypoventilation—A Consensus Conference Report
Section snippets
Overview
The use of nasal positive pressure ventilation (NPPV) has been increasing at a rate that is alarming to third-party payers and particularly to the Health Care Financing Administration (HCFA), which pays for services provided to Medicare beneficiaries. New prescriptions for NPPV have been most notable in patients with COPD and also in those patients with obstructive sleep apnea (OSA) who are deemed to be intolerant of continuous positive airway pressure (CPAP).
NPPV services for Medicare patients
Overview
A wide variety of restrictive thoracic diseases have been successfully treated with NPPV, including thoracic cage abnormalities (eg, chest wall deformities, kyphoscoliosis, spinal cord injury, and sequelae of polio), in addition to both rapidly and slowly progressive neuromuscular conditions (eg, amyotrophic lateral sclerosis [ALS] and a medley of myopathic/neuropathic disorders). Data from France presented by Dr. Leger indicated that from 1984 to 1996, their NPPV population grew in number from
Overview
Severe COPD is a major cause of morbidity and mortality worldwide. Few of the many available therapies have been shown to significantly improve long-term patient outcomes. Long-term oxygen therapy is the only treatment demonstrated to prolong survival in controlled trials.1819 Bronchodilator and anti-inflammatory medications are used mainly for symptomatic relief; studies on long-term outcomes have shown minor or no benefit.20Controlled trials have demonstrated that pulmonary rehabilitation
Overview
Normally the respiratory system responds to changes in oxygen uptake and carbon dioxide production to maintain normal homeostasis. Homeostasis is accomplished by changes in minute ventilation, which maintains Po2 and Pco2within a normal physiologic range. Alveolar hypoventilation, which can be defined as an elevation in Pco2 > 45 mm Hg, can occur in a number of disorders that can be referred to as the “hypoventilation syndromes.” Associated with alveolar hypoventilation is the development of
Additional Recommendations for All Forms of NPPV
Consensus conference participants also agreed on matters related to additional research as well as the actual “Certificate of Medical Necessity” that would be required for Medicare payment.
References (63)
- et al.
Severe hypercapnia after low-flow oxygen therapy in patients with neuromuscular disease and diaphragmatic dysfunction
Mayo Clin Proc
(1995) - et al.
Nocturnal nasal ventilation for treatment of patients with hypercapnic respiratory failure
Mayo Clin Proc
(1991) Hypoventilation: neuromuscular and chest wall disorders
Clin Chest Med
(1992)- et al.
French multicenter trial of prophylactic nasal ventilation in Duchenne muscular dystrophy
Lancet
(1994) - et al.
Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis
Mayo Clin Proc
(1991) - et al.
Nocturnal noninvasive positive pressure ventilatory assistance
Chest
(1996) - et al.
Extended therapy with ipratropium is associated with improved lung function in patients with COPD
Chest
(1996) - et al.
Effect of daily intermittent rest of respiratory muscles in patients with severe chronic airflow limitation (CAL)
Chest
(1984) Function and fatigue of respiratory muscles
Chest
(1985)- et al.
Effect of daily intermittent rest of respiratory muscles in patients with severe chronic airflow limitation (CAL)
Chest
(1984)
Changes in ventilatory muscle function with negative pressure ventilation in patients with severe COPD
Chest
Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease
Lancet
Efficacy of nocturnal nasal ventilation in stable, severe chronic obstructive pulmonary disease during a 3 month controlled trial
Mayo Clin Proc
Nasal intermittent positive pressure: long-term follow-up in patients with severe chronic respiratory insufficiency
Chest
Long term efficiency of home nasal mask ventilation in patients with diffuse bronchiectasis and severe chronic respiratory failure: a case control study
Chest
Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure
Chest
Sleep in patients with COPD
Clin Chest Med
ACCP consensus statement: indications for positive airway pressure treatment of adult obstructive sleep apnea patients
Chest
Night time nasal ventilation in neuromuscular disease
Lancet
Prescription of nCPAP and nBIPAP in obstructive sleep apnea syndrome
Respir Med
Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases
Chest
Assessment and treatment of sleep-disordered breathing in neuromuscular and chest wall diseases
Top Pulm Med
Effects of long-term nocturnal nasal ventilation on spontaneous breathing during sleep in neuromuscular and chest wall disorders
Eur Respir J
Treatment of alveolar hypoventilation in a 6 year-old girl with intermittent positive pressure ventilation through a nose mask
Am Rev Respir Dis
Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to trache-ostomy-intermittent positive pressure ventilation
J Neurol Sci
Long-term nasal ventilation in neuromuscular disorders: report of a consensus conference
Eur Respir J
Spirometry in amyotrophic lateral sclerosis
Arch Neurol
Conventional approaches to managing neuromuscular ventilatory failure
Home positive pressure ventilation via nasal mask for patients with neuromuscular weakness or restrictive lung or chest wall disease
Respir Care
Noninvasive ventilation
N Engl J Med
Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders
Thorax
Cited by (0)
From the conference facilitator was Allen Goldberg, MD, FCCP. Formal presenters included Patrick Leger, MD; Nicholas Hill, MD, FCCP; and Gerard Criner, MD, FCCP.
Participants and the organizations they represented included Edward Oppenheimer, MD, FCCP, the American Academy of Home Care Physicians; Vijay Deshpande, RRT, The American Association for Respiratory Care; Walter J. O’Donohue, Jr., MD, FCCP, the American College of Chest Physicians; Jonathon Truwit, MD, The American College of Physicians; Mark Sanders, MD, FCCP, The American Sleep Disorders Association; Barry Make, MD, FCCP, The American Thoracic Society; Peter Gay, MD, FCCP, the Mayo Clinic; and Neil Mac Intyre, MD, FCCP, and Frederick Oldenburg, Jr., MD, FCCP, the National Association for Medical Direction of Respiratory Care. The American Academy of Family Physicians declinedthe invitation to participate in the conference.
The conference was underwritten by an educational grant to NAMDRC fromthe Health Industry Manufacturers Association.
Correspondence to: Phillip Porte, National Association for Medical Direction of Respiratory Care, 5454 Wisconsin Avenue, Suite 1270,Chevy Chase, MD 20815-6901[email protected]